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A B S T R A C T
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of fertile age. Insulin 
can stimulate ovarian androgen production in normal women and in women with PCOS. Leptin levels were reduced among 
women with PCOS treated with insulin sensitizers. Aim: This study aims to investigate the serum levels of insulin and leptin in 
and their relationship with the endocrine and metabolic peculiarities of PCOS. Subjects and Methods: The study was carried out 
on 125 women during the reproductive age group, had primary infertility and diagnosed as having PCOS according to Rotterdam 
criteria. Patients were recruited from Tanta University Hospital, during the period May 2011 to December 2012. Cases were 
classified into two groups: Patient’s group comprised 75 women having PCOS and control group entailing 50 normal fertile 
healthy women. All women were subjected to: History taking, clinical examination, assessment of body mass index (BMI), 
ultrasonographic examination and hormonal assay to estimation serum leptin, insulin, follicle stimulating hormone, luteinizing 
hormone, progesterone and free testosterone value. Statistical analysis was performed by Statistical Product and Service 
Solutions (IBM, USA) version 10.0. Student t‑test was used to compare numerical variables while correlation was performed to 
determine the relationship between the variables. The value of P < 0.05 was taken as significant. Results: We found a significant 
positive correlation between leptin, BMI, age and a trivial upbeat correlation between leptin and insulin. The most interesting 
result is the significant positive correlation between insulin and leptin. Conclusion: There is a link between elevated serum leptin 
and insulin levels to obesity in PCOS suggesting that most probably they are responsible for the complicated picture of PCOS in 
obese patients.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is the most common 
endocrine disorder among women of fertile age. The 
prevalence of PCOS varies between 2.5% and 7.5%.[1] Its 
clinical manifestations include menstrual dysfunction and 
hyperandrogenic symptoms and it can be associated with 
metabolic dysfunction in which hyperinsulinemia and 
peripheral insulin resistance are central features.[1]
Insulin can stimulate ovarian androgen production in 
normal women and in women with PCOS. However, ovarian 
cells of women with PCOS display a higher responsiveness 
for insulin‑stimulated androgen synthesis in vitro. 
Non‑obese and normoinsulinemic women with PCOS 
significantly improve their serum testosterone levels after 
serum insulin levels are reduced. It is therefore, probable 
that women develop PCOS because of a hypersensitivity 
of their intra‑ovarian insulin androgen signaling pathway. 
The characterization of this potential defect could have 
significant implications for the development of specific and 
more efficient treatments of PCOS.[2]
Leptin, an appetite suppressant hormone produced in fat 
tissue, delivers at least a partially overlapping message to 
the neurons that critically control energy balance. Leptin 
plays a significant role in the regulation of body‑fat mass in 
animals and in humans.[3]
Leptin deficiency and PCOS appear to have a lot of 
similarities between their clinical, metabolically and 
biochemical features. However, in previous studies that 
have examined the relationship between leptin and PCOS, 
inconsistent findings have been reported. Although those 
with PCOS generally have significant insulin resistance, 
several investigators have demonstrated that leptin levels 
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are higher rather than lower in women with PCOS compared 
with weight‑matched control women, which leads to the 
conclusion of that insulin and leptin levels are positively 
correlated, implying a scenario that includes both insulin 
and leptin resistance.[4]
Leptin levels were shown to be reduced among women 
with PCOS treated with insulin sensitizers, Diazoxide and 
Metformin, suggesting that improved insulin sensitivity with 
associated decreased circulating insulin levels diminishes 
the insulin‑mediated stimulation of leptin production 
among affected women. Conversely, others have reported 
that independently of obesity, leptin levels do not differ 
significantly between women with PCOS and controls.[5]
The aim of this work was to investigate the serum levels of 
insulin and leptin in and their correlation with the endocrine 
and metabolic peculiarities of PCOS.
SUBJECTS AND METHODS
Subjects
This study was carried out on 125 females attending the 
out‑patient clinic of Tanta University Hospital seeking 
conception assistance. They were informed about the aim of 
the work and a written consent was taken from them. All 
women were in the reproductive age group, had primary 
infertility and diagnosed as having PCOS according to 
Rotterdam criteria. The most important exclusion criteria 
were: Women with other infertility factors, age over 30 years, 
receiving medicaments for any other diseases, women who 
had had induction of ovulation in previous cycles within 
6 months, evidence of systemic diseases, women on hormonal 
contraception, women on dietary food regimen and women 
with other causes of hirsutism and oligoamenorrhea. Patients 
included within this study were classified under three groups
Patient’s group: Included 75 women having PCOS.
Control group: This group included 50 normal fertile healthy 
women, received no hormonal medication during the last 
6 months preceding the study (control group).
Methods
All women included within this study were subjected to: 
History taking, clinical examination and assessment of body 
mass index (BMI), ultrasonographic examination.
Informed consent was obtained from all patients according 
to local procedures in accordance the declaration of Helsinki. 
The ethical committees at the department approved the 
protocol.
A total volume of 5 ml of the venous blood was taken from 
each case in the morning of the 3rd day throughout the 
cycle to measure fasting serum concentrations of follicle 
stimulating hormone (FSH), luteinizing hormone (LH) 
and free testosterone values. The hormonal assays were 
carried out by enzyme‑linked immunosorbent assay (ELISA) 
technique. ELISA kits for leptin and insulin were supplied 
by DRG laboratories Ltd. ELISA kits for progesterone 
and testosterone were supplied by Dia Metra Laboratory 
Limited. Estimations of serum levels of FSH and LH were 
performed by radio‑immunoassays.
Serum concentrations of leptin, insulin and progesterone 
were measured in the morning, fasting, of all cases during 
the mid‑cycle period.
Statistical analysis was performed by Statistical Product and 
Service Solutions version 10.0. (IBM, USA) Student t‑test 
was used to compare numerical variables while correlation 
was performed to determine the relationship between the 
variables. The value of P < 0.05 was taken as significant.
RESULTS
The clinical data of the studied cases are depicted in 
Table 1. It is evident that members of both the control and 
PCOS were well‑matched concerning age and BMI.
The hormonal profiles of the studied cases clarify that 
women having PCOS had significantly higher serum 
concentrations of LH, free testosterone, insulin and leptin 
than the corresponding values of the control cases. On the 
contrary, serum progesterone was appreciably lower for 
PCOS cases than in the controls [Table 2].
Serum leptin level rises in both studied groups (control and 
PCOS) with raised BMI as demonstrated in Table 3. However, 
the increase in serum leptin was much higher in PCOS group 
than the controls, particularly among overweight and obese 
cases suggesting a sort of relationship with PCOS.
Serum insulin was insignificantly higher in PCOS than in the 
control cases. The rise in insulin value is in direct proportion 
to the body weight. These facts are shown in Table 4.
Statistical analysis on the results, using Pearson’s 
correlation matrix, as depicted in Table 5, the presence 
of significant positive correlation between leptin and age, 
leptin and BMI. On the other side, we found substantial 
negative correlation between insulin and age and between 
BMI and LH:FSH ratio.
Table 1: The clinical data of the studied patients







Age (years) 25.5 (3.9) 24 (3.7) 0.034
BMI (kg/m2) 24.3 (2.6) 25.7 (2.5) 0.025










NS – Non‑significant; BMI – Body mass index; SD – Standard deviation
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DISCUSSION
Women with PCOS are hyperandrogenic and most of them 
are obese. The impact of obesity is usually considered to 
operate through the associated insulin resistance.[6]
It has become apparent that insulin resistance and 
hyperinsulinemia play a critical role in PCOS pathogenesis. 
Despite advances over the past decade, many of the 
questions remain regarding both the nature of insulin 
resistance in PCOS and the mechanism by which insulin 
resistance or insulin produces hyperandrogenemia.[2]
The present study was designed to assess serum levels of 
insulin and leptin in and their correlation with the endocrine 
and metabolic peculiarities of PCOS. In this study, we found 
that the mean patient’s age was 25.2 ± (3.8) years. We found 
that leptin levels alter significantly with age. This does not 
agree with the results of other previous studies that found 
that serum leptin is not affected by changes in age.[7]
The mean BMI of women with PCOS was 24.9 (2.6) kg/m2. 
The mean duration of infertility (in the PCOS groups I and 
II) was 3.8 (1.7) years. Women of the control group were in 
the obese side as their mean BMI was slightly higher than 
25 kg/m2 as PCOS cases that are to remove bias of obesity.
Women included within this study represent a homogenous 
group of the population, as regards age, BMI and infertility 
duration with insignificant differences. When comparing the 
clinical characteristics of the PCOS women in both groups, 
there were more women with hirsutism in the clomiphene 
citrate (CC) non‑respondent group than in the CC respondent 
women, but this was statistically insignificant.
In the present study, we noticed that serum leptin level was 
significantly elevated in women with PCOS when compared 
to women with normal menstrual cycles and matched BMI. 
Serum leptin concentrations in women with PCOS have 
been reported to be higher than[8‑10] or similar to[11,12] those 
in weight matched controls. On the contrary, Caro reported 
that leptin mean value was not different in PCOS patients 
compared with the normal controls.[13]
Okasanen et al. a concluded that PCOS is not a consequence 
of mutations of the leptin or leptin receptor genes, and 
they stated that the hypothesis that variations in the leptin 
receptor gene locus affect insulin regulation and this 
hypothesis was further supported by our study.[14]
By comparing serum fasting insulin concentration in different 
groups of our present study, we found that there was a 
significant hyperinsulinemia in both PCOS groups when 
compared with the control group (P < 0.5). In addition, the 
results showed more significance in the second group (CC 
resistant group) with high significant difference (P < 0.01). 
Our findings agree with those reported by Ehrmann et al.,[15] 
who found significant higher fasting insulin in women with 
PCOS than normal controls. Our results also go with that 
found by Tarkun et al.[16]
On the contrary, our results do not agree with those who 
found a non‑significant difference between PCOS patients 
and control group in regard to serum insulin; although it 
was higher among the PCOS group, this can be explained 
by the fact that most of their studied PCOS women were 
not obese.[17]
Numerous studies have demonstrated that any treatment 
aimed at improving insulin resistance in women with PCOS 
results in lower androgen levels and improves ovulatory 






FSH (mIU/ml) 5.1 (1.2) 5.0 (1.2) 0.40
LH (mIU/ml) 5.5 (1.4) 8.5 (2.5) 0.04
LH:FSH ratio 1.1 (0.2) 1.6 (0.7) 0.03
Free testosterone (pg/ml) 1.2 (0.1) 1.5 (0.9) 0.04
Progesterone (ng/ml) 5.5 (1.8) 2.5 (0.8) 0.02
Insulin (µlU/ml) 12.6 (3.3) 16.3 (3.5) 0.04
Leptin (ng/ml) 20.8 (2.7) 26.5 (7.0) 0.04
FSH – Follicle stimulating hormone; LH – Luteinizing hormone; SD – Standard deviation
Table 3: Serum leptin concentrations in relation to BMI in 
the studied groups
BMI (kg/m2) Control Patients
Lean (<25) 19.8 24.1
Overweight (25‑30) 20.82 28.8*
Obese (>30) 27.2 30.7*
*Statistically significant at P<0.05 using spearman correlations test. Notice that serum leptin 
concentrations were higher in obese than in non‑obese women (P<0.05). BMI – Body mass index
Table 4: Serum insulin concentration in relation to BMI in 
the studied groups
BMI (kg/m2) Control Patients
Lean (<25) 11.2 15.1
Overweight (25‑30) 14.2 17.3
Obese (>30) 11.6 20.1
N.B. There is no significant differences between PCOS and control cases. PCOS – Polycystic 
ovary syndrome; BMI – Body mass index
Table 5: Pearson’s correlation matrix among cases with PCOS
Age BMI LH:FSH Leptin Insulin
Age ‑ 0.17 −0.21 0.04* −0.02*
BMI 0.17 ‑ −0.04* 0.02* 0.20
LH:FSH −0.21 −0.04* ‑ 0.20 0.16
Leptin 0.04* 0.02* 0.2 ‑ 0.09
Insulin −0.02* 0.2 0.16 0.09 ‑
*Statistically significant at P<0.05 using spearman correlations test. N.B. It is clear that in women 
with PCOS, there is a significant positive correlation between serum leptin, BMI and patient’s 
age. PCOS – Polycystic ovary syndrome; BMI – Body mass index; FSH – Follicle stimulating 
hormone; LH – Luteinizing hormone
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function.[4] Yet, this hypothesis was supported by other 
results, either concerned with a normal insulin level in 
PCOS patients[18] or demonstrated a similar degree of insulin 
resistance in ovulatory and anovulatory obese subjects.[19,20]
In the present investigation, we found a positive correlation 
between BMI and serum leptin in different groups of 
this study with a more positive correlation in the CC 
non‑responders group. Furthermore, there was a positive 
correlation between BMI and serum fasting insulin in 
different groups within the study with a more positive 
correlation in PCOS and CC responders group. These results 
support the previously published data demonstrating 
a positive correlation between serum leptin, levels 
and BMI.[11,21] The relationship between BMI and leptin 
concentrations was present in women with PCOS as well; 
these results came in agreement with other studies.[16,22,23] 
However, Kale‑Gurbuz et al. reported that among obese 
adolescents with PCOS, adiponectin and leptin levels do not 
seem to be determined by the existence of PCOS.[24]
It can be seen that there was a positive correlation between 
leptin, BMI and age and this was statistically significant. 
Although a positive correlation was found between leptin 
and insulin but couldn’t reach a statistically significant 
result. Yet, a positive correlation was found between age 
and insulin and this was statistically significant. These 
results suggest that it may be not the insulin that plays 
the major role in the pathophysiology of the syndrome and 
that increased insulin is probably an effect rather than a 
cause in obese PCOS patients and this in agreement with 
Conn.[25]
The most outstanding finding of our current work was 
the significant positive correlation that detected between 
serum insulin and leptin levels. This agrees with that stated 
by Bloomgarden[26] who found that insulin acutely increases 
plasma leptin and reduces adiponectin, suggesting a role of 
hyperinsulinemia in insulin resistance, which is associated 
to an increase in adipocyte inflammatory factors.
As PCOS is a well‑characterized state of insulin resistance 
with compensatory hyperinsulinemia,[27] it was not 
surprising that the hyperinsulinemia in obese women with 
PCOS results in a highly significant increase of leptin levels 
within this group compared with age and weight‑matched 
control in the present study.
It seems that elevated serum leptin level seems to be the 
responsible mediator for the pathology of PCOS, most 
probably through dual mechanism. The first mediated at 
the central level through rising LH secretion, which in turn 
increase’s androgen production, and the second mechanics, 
is mediated at the peripheral level by direct inhibitory 
effect of leptin on the ovaries causing an increase in the 
androgenic media.[28,29] Hence, there is a significant role of 
serum leptin in the determination of insulin resistance in 
PCOS patients.[30]
On the other hand, the present study links the elevated 
serum leptin and insulin levels to obesity suggesting that 
most probably they are responsible for the complicated 
picture of the syndrome in obese patients. A hypothesis 
that can be easily explained by the direct effect of insulin 
on leptin expression causing more inhibitory action of 
leptin on the ovary and also the insulin and LH effect on the 
androgen level.
REFERENCES
1. Taylor AE. Insulin‑lowering medications in polycystic ovary syndrome. 
Obstet Gynecol Clin North Am 2000;27:583‑95.
2. Baillargeon J, Nestler J. Polycystic ovary syndrome: A syndrome 
of ovarian, hypersensitivity to insulin? J Clin Endocrinol Metab 
2005;10:1804.
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, 
et al. Weight‑reducing effects of the plasma protein encoded by the 
obese gene. Science 1995;269:543‑6.
4. Spritzer PM, Poy M, Wiltgen D, Mylius LS, Capp E. Leptin concentrations 
in hirsute women with polycystic ovary syndrome or idiopathic 
hirsutism: Influence on LH and relationship with hormonal, metabolic, 
and anthropometric measurements. Hum Reprod 2001;16:1340‑6.
5. Fedorcsák P, Storeng R, Dale PO, Tanbo T, Torjesen P, Urbancsek J, et al. 
Leptin and leptin binding activity in the preovulatory follicle of polycystic 
ovary syndrome patients. Scand J Clin Lab Invest 2000;60:649‑55.
6. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, 
et al. Effect of long‑term treatment with metformin added to 
hypocaloric diet on body composition, fat distribution, and androgen 
and insulin levels in abdominally obese women with and without the 
polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767‑74.
7. Considine RV, Caro JF. Protein kinase C: Mediator or inhibitor of 
insulin action? J Cell Biochem 1993;52:8‑13.
8. Vicennati V, Gambineri A, Calzoni F, Casimirri F, Macor C, Vettor R, 
et al. Serum leptin in obese women with polycystic ovary syndrome 
is correlated with body weight and fat distribution but not with 
androgen and insulin levels. Metabolism 1998;47:988‑92.
9. El Orabi H, Ghalia AA, Khalifa A, Mahfouz H, El Shalkani A, Shoieb N. 
Serum leptin as an additional possible pathogenic factor in polycystic 
ovary syndrome. Clin Biochem 1999;32:71‑5.
10. Mantzoros CS, Cramer DW, Liberman RF, Barbieri RL. Predictive value 
of serum and follicular fluid leptin concentrations during assisted 
reproductive cycles in normal women and in women with the 
polycystic ovarian syndrome. Hum Reprod 2000;15:539‑44.
11. Rouru J, Anttila L, Koskinen P, Penttilä TA, Irjala K, Huupponen R, 
et al. Serum leptin concentrations in women with polycystic ovary 
syndrome. J Clin Endocrinol Metab 1997;82:1697‑700.
12. Takeuchi T, Tsutsumi O. Basal leptin concentrations in women with 
normal and dysfunctional ovarian conditions. Int J Gynaecol Obstet 
2000; 69:127‑33.
13. Caro JF. Leptin is normal in PCOS, an editorial about three “negative” 
papers. J Clin Endocrinol Metab 1997;82:1685‑6.
14. Okasanen L, Tiitinen A, Kaprio J, Koistinen HA, Karonen S. No evidence 
for mutations of the leptin receptor genes in women with polycystic 
ovary syndrome. Fertil Steril 2000;66:942‑8.
15. Ehrmann D, Liljenquist DR, Kasza K. Prevalence and predictors 
of the metabolic syndrome in women with Polycystic Ovary 
Syndrome (PCOS). J Clin Endocrinol Metab 2005;10:1210.
EL‑Gharib and Badawy: Insulin and leptin in PCOS
Journal of Basic and Clinical Reproductive Sciences · January - June 2014 · Vol 3 · Issue 1 53
16. Tarkun I, Cantürk Z, Arslan BC, Türemen E, Tarkun P. The plasminogen 
activator system in young and lean women with polycystic ovary 
syndrome. Endocr J 2004;51:467‑72.
17. Mallique M, Perg‑Bravo F, Calvihon M, Piwonka V. Relationship 
between leptin and insulin sensitivity in patients with PCOS. Med 
Clin Brac 1999;133:526‑30.
18. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, 
Schoemaker J. Polycystic ovaries in adolescents and the relationship 
with menstrual cycle patterns, luteinizing hormone, androgens, and 
insulin. Fertil Steril 2000;74:49‑58.
19. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. 
Effects of metformin on early pregnancy loss in the polycystic ovary 
syndrome. J Clin Endocrinol Metab 2002;87:524‑9.
20. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization 
of groups of hyperandrogenic women with acanthosis nigricans, 
impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol 
Metab 1987;65:499‑507.
21. Jeon YE, Lee KE, Jung JA, Yim SY, Kim H, Seo SK, et al. Kisspeptin, 
leptin, and retinol‑binding protein 4 in women with polycystic ovary 
syndrome. Gynecol Obstet Invest 2013;75:268‑74.
22. Gennarelli G, Holte J, Wide L, Berne C, Lithell H. Is there a role for 
leptin in the endocrine and metabolic aberrations of polycystic ovary 
syndrome? Hum Reprod 1998;13:535‑41.
23. Kedikova SE, Sirakov MM, Boyadzhieva MV. Leptin levels and adipose 
tissue percentage in adolescents with polycystic ovary syndrome. 
Gynecol Endocrinol 2013;29:384‑7.
24. Kale‑Gurbuz T, Akhan SE, Bastu E, Telci A, Iyibozkurt AC, Topuz S. 
Adiponectin, leptin and ghrelin levels in obese adolescent girls with 
polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2013;26:27‑30.
25. Conn JJ, Jacobs HS, Conway GS. The prevalence of polycystic ovaries 
in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 
2000;52:81‑6.
26. Bloomgarden ZT. Second World Congress on the Insulin Resistance 
Syndrome: Mediators, pediatric insulin resistance, the polycystic 
ovary syndrome, and malignancy. Diabetes Care 2005;28:1821‑30.
27. Book CB, Dunaif A. Selective insulin resistance in the polycystic ovary 
syndrome. J Clin Endocrinol Metab 1999;84:3110‑6.
28. Blüher S, Mantzoros CS. The role of leptin in regulating neuroendocrine 
function in humans. J Nutr 2004;134:2469S‑74.
29. Fekete C, Singru S, Sanchez E. Differential effects of central 
leptin, insulin or glucose administration during fasting on the 
Hypothalamic‑Pituitary‑Thyroid (HPT) axis and feeding‑related 
neurons in the arcuate nucleus. Endocrinology 2005;10:1210‑40.
30. Lichnovská R, Gwozdziewiczová S, Chlup R, Hrebícek J. Serum leptin 
in the development of insulin resistance and other disorders in the 
metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc 
Czech Repub 2005;149:119‑26.
How to cite this article:*** 
 
Source of Support: Nil, Conflict of Interest: None declared
